A Review on Pyrazole Derivatives Used in the Treatment of Rheumatoid Arthritis: Recent Advancement and Drug Development

被引:0
|
作者
Choudhary, Nisha [1 ]
Sharma, Neeraj [2 ]
机构
[1] Chandpur Pharm Coll, Fac Pharm, Chandpur, UP, India
[2] Bhagwant Univ, Fac Pharm, Ajmer, Rajasthan, India
关键词
Azoles; arthritis; synovial joint; stereochemistry; tautomerism; combinatorial synthesis; SELECTIVE COX-2 INHIBITORS; BIOLOGICAL EVALUATION; ANTIVIRAL ACTIVITY; MOLECULAR DOCKING; ANTICANCER; DESIGN; RECEPTOR; ANALOGS; ACTIVATION; DISCOVERY;
D O I
10.2174/0115733971267325231227092819
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is an autoimmune disorder where inflammation and destruction of bone are the hallmarks of the disease. This review focuses on the etiology, pathophysiology, and treatment strategies for RA, along with the different approaches used for the synthesis of pyrazoles, the characterization of various properties, and their biological significance for curing RA. The activated immune system of the body causes inflammation of the synovial joint due to the interaction of immune cells, such as T and B lymphocytes, macrophages, plasma cells, dendritic cells and mast cells. The treatment for RA has been revolutionized with the discovery of new chemical compounds and an understanding of their mechanism in the treatment of the disease. Pyrazoles are the starting materials for the synthesis of heterocyclic compounds and possess great relevance in the pharmaceutical field for the development of new drugs. They are versatile bio-scaffolds in medicinal chemistry and organic synthesis. This has been followed by a deep analysis of pyrazoles and their derivatives on the basis of medical significance in the treatment of RA. This follow-up and information may help the chemists, scientists, and researchers to generate new pyrazole compounds with high efficacy for better treatment of patients with RA. We summarize the review with an understanding of the core of pyrazoles and a claim that their derivatives may be helpful in the development of efficient drugs against RA.
引用
收藏
页码:54 / 69
页数:16
相关论文
共 50 条
  • [41] A review of sarilumab for the treatment of rheumatoid arthritis
    Lee, Eun Bong
    IMMUNOTHERAPY, 2018, 10 (01) : 57 - 65
  • [42] Review of tocilizumab in the treatment of rheumatoid arthritis
    Okuda, Yasuaki
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 75 - 82
  • [43] Abatacept for the treatment of rheumatoid arthritis: A review
    Kaine, Jeffrey L.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2007, 68 (06): : 379 - 399
  • [44] DRUG-TREATMENT OF RHEUMATOID-ARTHRITIS
    BROOKS, PM
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1978, 8 : 101 - 105
  • [45] THE DEVELOPMENT OF IMMUNOCYTOKINES FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Gofur, Y.
    Chernajovsky, Y.
    RHEUMATOLOGY, 2002, 41 : 28 - 29
  • [46] Drug Insight: abatacept for the treatment of rheumatoid arthritis
    Eric M Ruderman
    Richard M Pope
    Nature Clinical Practice Rheumatology, 2006, 2 : 654 - 660
  • [47] Drug delivery systems for the treatment of rheumatoid arthritis
    Tarner, Ingo H.
    Mueller-Ladner, Ulf
    EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (09) : 1027 - 1037
  • [48] DRUG-TREATMENT IN RHEUMATOID-ARTHRITIS
    GEBEST, HJ
    INNERE MEDIZIN, 1987, 14 (05) : 179 - 183
  • [49] Drug Insight: abatacept for the treatment of rheumatoid arthritis
    Ruderman, Eric M.
    Pope, Richard M.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (12): : 654 - 660
  • [50] Liposomal Drug Formulations in the Treatment of Rheumatoid Arthritis
    van den Hoven, Jolanda M.
    Van Tomme, Sophie R.
    Metselaar, Josbert M.
    Nuijen, Bastiaan
    Beijnen, Jos H.
    Storm, Gert
    MOLECULAR PHARMACEUTICS, 2011, 8 (04) : 1002 - 1015